USD 84.91 Million
Report ID:
SQMIG35I2140 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
65 |
Figures:
75
Global 3D Printed Drugs Market size was valued at USD 84.91 Million in 2022 and is poised to grow from USD 98.5 Million in 2023 to USD 322.91 Million by 2031, at a CAGR of 16% during the forecast period (2024-2031).
The global 3D Printed Drugs market is a rapidly growing sector in the pharmaceutical industry. 3D printing technology is being increasingly used to create customized drug formulations, which can improve drug efficacy, reduce side effects, and provide personalized dosing. The 3D printing process involves creating a three-dimensional object by laying down successive layers of material, and in the case of drug manufacturing, this involves printing precise doses of drugs onto a substrate. North America dominates the market, followed by Europe and Asia Pacific. The growth of the market can be attributed to the increasing demand for personalized medicines, the ability of 3D printing to provide precise dosing and reduce side effects, and advancements in technology. The purpose of the 3D printed drugs market is to provide a new and innovative way of manufacturing drugs that can improve patient outcomes and reduce healthcare costs. The use of 3D printing technology in drug manufacturing can provide greater flexibility in drug design, reduce waste, and allow for the production of drugs on demand. The major driving factors for the growth of the 3D printed drugs market include increasing demand for personalized medicines, advancements in technology, the ability of 3D printing to provide precise dosing and reduce side effects, and the need to reduce healthcare costs. The major restraining factors for the growth of the 3D printed drugs market include the high cost of 3D printing technology and regulatory challenges associated with the approval of 3D printed drugs. The challenges in the 3D printed drugs market include the need for further research and development to ensure the safety and efficacy of 3D printed drugs, the need for standardization of 3D printing processes, and the potential for intellectual property disputes. The opportunities in the 3D printed drugs market include the development of new and innovative drug formulations, the expansion of the market to new regions, and the potential for 3D printing to transform drug delivery and personalized medicine. The use of 3D printing technology in drug manufacturing could also provide new revenue streams for pharmaceutical companies.
US 3D Printed Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 84.91 Million
Largest Segment
Zip Dose Technology
Fastest Growth
Zip Dose Technology
Growth Rate
16% CAGR
To get more reports on the above market click here to Buy The Report
The global 3D printed drugs market is segmented on the basis of product, application, and region. By technology, the market is segmented into inkjet printing, fused deposition modeling, stereolithography, zipdose technology. By application, the market is segmented into orthopedic, neurology, dental, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
3D Printed Drugs Market Analysis by Technology
In 2022, the zip dose segment held the highest share of the market .This drug technology is easy to use and beneficial to patients with dysphagia. an increasing requirement among geriatric & pediatric patients for rapid soluble drugs that disperse quickly in the mouth drives the market growth. Inkjet printer technology, on the other hand, is anticipated to expand at the fastest rate during the projected period. As it generates 3D drugs at a steady rate and has technological superiority over other techniques, it has a high adoption rate among patients. Inkjet printing is a method of depositing three-dimensional shapes in solid dosage forms by spraying various combinations of active pharmaceutical ingredients and excipients (inks) through a nozzle. Increased epilepsy incidences, continued technological advancements in 3D printing technology, and expanding awareness of this technology in emerging nations are primary market growth drivers.
3D Printed Drugs Market Analysis by Application
The neurology segment dominated the market with a share of 49.84% in 2022. In August 2015, the U.S. FDA approved Aprecia Pharmaceuticals SPRITAM (levetiracetam) tablets for the treatment of people with epilepsy. This is the only approved drug available on the market. This approval has gained the attention of pharmaceutical companies to invest in this segment thereby propelling the market growth.
The segment is also propelled by an increase in the prevalence of various neurological disorders such as Parkinson's disease. In an article published in April 2022, a team of scientists from Germany and the Netherlands used 3D printing technology for the manufacturing of Mini-Floating-Polypill as a therapy for Parkinson’s disease. Fused deposition modeling (FDM) was used for this study. Such research efforts are anticipated to supplement the segment growth. On the other hand, orthopedic procedures are complex & tough, and new approaches are needed to overcome a slew of known issues and better patient outcomes. In addition, complications, particularly the high rate of infection, frequently result in extended patient suffering and functional loss. Thus, orthopedic drugs can be used to combat postoperative infections, hence, propelling the market growth.
To get detailed analysis on other segments, Request For Free Sample Report
In 2022, North America dominated the regional market with a share of 38.23%. This major share can be attributed to an increased incidence of chronic diseases, the presence of excellent domestic healthcare infrastructure, strong investment in R&D, and the expanding use of technological developments in the North America region.
The Asia Pacific is estimated to be the fastest-growing region due to significant developments by China and Japan in the technological integration of 3D printed drug methodologies. Moreover, the development of healthcare infrastructure, R&D, and clinical development frameworks of emerging economies such as India and Australia have poised the Asia Pacific market to witness lucrative opportunities and growth throughout the forecast period.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
3D Printed Drugs Market Drivers
Increasing Demand for Personalized Medicines
Advancements in Technology
3D Printed Drugs Market Restraints
High Cost of 3D Printing Technology
Regulatory Challenges
Request Free Customization of this report to help us to meet your business objectives.
The global 3D printed drugs market is very competitive in nature owing to various strategies including partnerships through geographical expansion, mergers and acquisitions, and strategic collaborations to expand their market presence. The business manufactures a variety of prescription drugs and vaccinations. The pharmaceutical industry finds, creates, and sells drugs to treat both acute and chronic illnesses. The vaccines industry offers vaccinations for individuals of all ages, from infants and adolescents to adults and senior citizens. Its product line includes HIV and respiratory medications. Respiratory, HIV, Specialty Products, and Classic and Established Products are all part of its pharmaceuticals division. Over 40 vaccinations for children, adolescents, adults, older adults, and travellers are included in the company's vaccine portfolio.
3D Printed Drugs Market Top Player’s Company Profiles
3D Printed Drugs Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The Global 3D Printed Drugs Market is expected to experience significant growth during the forecast period from 2022 to 2030. The global 3D Printed Drugs market refers to the market for pharmaceuticals that are manufactured using 3D printing technology. 3D printing, also known as additive manufacturing, involves the layer-by-layer creation of three-dimensional objects using a digital model. The technology has the potential to revolutionize the pharmaceutical industry by allowing for the customization of drugs to meet specific patient needs. The market for 3D printed drugs is expected to grow significantly in the coming years. The market is driven by the increasing demand for personalized medicine, as well as the benefits of 3D printing in drug development, such as the ability to produce complex drug formulations with precise dosing. The global 3D printed drugs market is a growing market with significant potential for growth in the coming years. The market is driven by the increasing demand for personalized medicine and the benefits of 3D printing technology in drug development.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 84.91 Million |
Market size value in 2031 | USD 322.91 Million |
Growth Rate | 16% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Million |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the 3D Printed Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the 3D Printed Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the 3D Printed Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the 3D Printed Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2140